Coverdine 10mg/2.5mg/10mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

coverdine 10mg/2.5mg/10mg film-coated tablets

originalis b.v. - perindopril arginine; indapamide; amlodipine - film-coated tablet - ace inhibitors, other combinations; perindopril, amlodipine and indapamide

Triplixam 2.5mg/0.625mg/5mg film-coated Tablets Malta - English - Medicines Authority

triplixam 2.5mg/0.625mg/5mg film-coated tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, perindopril arginine, indapamide - film-coated tablet - amlodipine 5 mg perindopril arginine 2.5 mg indapamide 0.625 mg - agents acting on the renin-angiotensin system

Triplixam 5mg/1.25mg/5mg film-coated Tablets Malta - English - Medicines Authority

triplixam 5mg/1.25mg/5mg film-coated tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, perindopril arginine, indapamide - film-coated tablet - amlodipine 5 mg perindopril arginine 5 mg indapamide 1.25 mg - agents acting on the renin-angiotensin system

Triplixam 5mg/1.25mg/10mg film-coated Tablets Malta - English - Medicines Authority

triplixam 5mg/1.25mg/10mg film-coated tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, perindopril arginine, indapamide - film-coated tablet - amlodipine 10 mg perindopril arginine 5 mg indapamide 1.25 mg - agents acting on the renin-angiotensin system

Triplixam 10mg/2.5mg/5mg film-coated Tablets Malta - English - Medicines Authority

triplixam 10mg/2.5mg/5mg film-coated tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, perindopril arginine, indapamide - film-coated tablet - amlodipine 5 mg perindopril arginine 10 mg indapamide 2.5 mg - agents acting on the renin-angiotensin system

Triplixam 10mg/2.5mg/10mg film-coated Tablets Malta - English - Medicines Authority

triplixam 10mg/2.5mg/10mg film-coated tablets

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - amlodipine, perindopril arginine, indapamide - film-coated tablet - amlodipine 10 mg perindopril arginine 10 mg indapamide 2.5 mg - agents acting on the renin-angiotensin system

Perindopril Arginine/Amlodipine 10/10 APOTEX perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 10/10 apotex perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

Perindopril Arginine/Amlodipine 5/5 APOTEX perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

perindopril arginine/amlodipine 5/5 apotex perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.